Omega Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Omega Therapeutics Stock Summary

Omega Therapeutics competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, and Olema Pharmaceuticals. Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Omega Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.

Omega Therapeutics Key Financial Ratios

Omega Therapeutics Key Balance Sheet Accounts

Omega Therapeutics Key Income Statement Accounts

Omega Therapeutics Key Cash Accounts

Omega Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Omega Therapeutics's current stock value. Our valuation model uses many indicators to compare Omega Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Omega Therapeutics competition to find correlations between indicators driving Omega Therapeutics's intrinsic value. More Info.Omega Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Omega Therapeutics' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Omega Therapeutics' earnings, one of the primary drivers of an investment's value.

Omega Therapeutics Systematic Risk

Today, most investors in Omega Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Omega Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Omega Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Omega Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Omega Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Omega Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Omega Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Omega Therapeutics's daily price indicators and compare them against related drivers.

When running Omega Therapeutics' price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.